Health Care Financing In Ghana–A Case Study of Allocation of Funds under the Ghana Diagnosis Related Grouping (G-DRG) Of the NHIS in Accra.

BARBARA AMISSAH BINEY.pdf

Dublin Core

Title

Health Care Financing In Ghana–A Case Study of Allocation of Funds under the Ghana Diagnosis Related Grouping (G-DRG) Of the NHIS in Accra.

Creator

Barbara Amissah Biney

Description

The study was conducted in the Greater Accra Metropolis and Tema Metropolis of the Ghana Diagnosis Related Grouping (G-DRG) of the National Health Insurance Scheme (NHIS) to evaluate health care financing in Ghana a case of study of allocation of funds under the G-DRG
of the NHIS in Accra. A content validated questionnaire and interview sections were used to seek relevant information from appropriate facility managers and scheme managers who matter in the NHIS.
The study employed descriptive research as its research design. The target population for the study was 134 government and private hospitals sampled from about 250 government and private hospitals within Accra and Tema Metropolis. The researcher adopted purposive and simple random sampling techniques to sample the target population which comprise of clinics, Polyclinics and Primary Hospital, Secondary Hospitals, Tertiary Hospital, Pharmacies and the Research, Policy and Monitoring and Evaluation Directorate of the NHIS. Statistical Package for
Social Science (SPSS) was used to analyze data collected and findings presented via descriptive analysis and bar chat, tables, pie chat and figures.
The main findings of the study established that, G-DRG was introduced under the NHIS system as a best approach for sustainable healthcare financing under the NHIS system and also, the mediating factor for universal healthcare coverage is to ensure efficient use of resources, improved pooling coupled with resource mobilization.
Finally the study observed that, financial sustainability of the scheme was a challenge to the scheme. The study recommended that, it is important for NHIA which is a regulated body, to make it a point to review drug prices to reflect the market changing prices.

Subject

MBA Finance

Date

MAY, 2018